Based on the results of cytokine arrays and proteomic analysis we selected AREG, CXCL8, DPP4, EGF, FN1, HEBP1 and MMP1 for ELISA validation in CM from five RCC-derived cell lines and RPTEC cells (Fig. 3). This evidence concerns the gene FN1 and renal cell carcinoma.